• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Science & Research

  • Print
  • Share
  • E-mail

Dialogues on Diversifying Clinical Trials

Successful Strategies for Engaging Women and Minorities

L'Enfant Plaza Hotel, Washington, DC

September 22-23, 2011

 

The FDA Office of Women's Health in collaboration with the Society for Women's Health Research held a two-day conference to share a best practices approach to successful and innovative recruitment, retention, and analysis of women and minorities in clinical research. Over 200 representatives from government, industry, patient advocates, and the scientific community came together to discuss strategies for increasing the participation of women and minorities in clinical trials.

The conference included roundtable discussions and presentations on research design, cultural and linguistic competency, federal policies and regulations, and community collaborations. The meeting also featured welcoming remarks by FDA Commissioner Margaret Hamburg and DHHS Deputy Assistant Secretary Garth Graham.

 

 

 

A special thank you to the FDA Office of Minority Health for their support and assistance with this conference.

 

Contact FDA

301-796-9440
Fax:301-847-8604
Food and Drug Administration Office of Women's Health

10903 New Hampshire Avenue

WO32-2333

Silver Spring, MD 20993